ASH18: CAR-T shows up in early CLL test

ASH18: CAR-T shows up in early CLL test

Source: 
Biopharma Dive
snippet: 

A CAR-T cell therapy acquired by Celgene earlier this year could have a path forward in chronic lymphocytic leukemia (CLL), showing initial signs of efficacy in a small group of heavily pretreated patients with the blood cancer.